GBI Bio Employee Directory
Biotechnology ResearchFlorida, United States51-200 Employees
GBI Bio, based near Fort Lauderdale, Florida, operates as an integrated cGMP contract development and manufacturing organization serving biosimilars, monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates, and other bioconjugates. Its scope includes cell line development, GMP master cell banking, proof-of-concept studies, cell culture, purification, and bioconjugation process development, along with scale-up and GLP pilot manufacturing for toxicology studies and cGMP fill-finish for human clinical trials. Analytical development and qualification, microbiological quality control, and quality assurance and regulatory affairs support are provided to aid regulatory readiness. With more than two decades of experience as an independent CDMO, GBI Bio has partnered with academic research institutions, early-stage biotech startups, and multinational companies. The company operates within the biotechnology research sector, emphasizing a single-source approach to advancing complex biologics for its customers. In January 2026, GBI Biomanufacturing announced the appointment of Jesse McCool, Ph.D., as president.